Board Meeting13 Aug 2026, 10:41 am
Vista Pharmaceuticals Board Meeting on Aug 14 to Review Q1 Results
AI Summary
Vista Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. Additionally, the board will review the Limited Review Report for the same period. The meeting will take place at the company's registered office.
Key Highlights
- Board meeting scheduled for August 14, 2026.
- To consider unaudited financial results for Q1 FY27.
- Limited Review Report for Q1 FY27 to be discussed.
- Meeting to be held at the company's registered office.
Price Impact
More from VISTAPH